| Q28394003 | Animal models of peripheral neuropathy due to environmental toxicants |
| Q46563657 | Antiapoptotic efficacy of folic acid and vitamin B₁₂ against arsenic-induced toxicity. |
| Q28392204 | Arsenic exposure and toxicology: a historical perspective |
| Q24815356 | Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? |
| Q44035228 | Arsenic in drinking water and peripheral nerve conduction velocity among residents of a chronically arsenic-affected area in Inner Mongolia |
| Q42275204 | Assessment of exposure to arsenic among smelter workers: a five-year follow-up |
| Q37698420 | Biomonitoring for environmental exposures to arsenic |
| Q82028949 | Chapter 42 Specific painful neuropathies |
| Q34485388 | Chronic arsenic toxicity in Bangladesh and West Bengal, India--a review and commentary. |
| Q57952025 | Clinical Symptoms, Neurological Signs, and Electrophysiological Findings in Surviving Residents with Probable Arsenic Exposure in Toroku, Japan |
| Q39738871 | Clinical and environmental aspects of arsenic toxicity |
| Q28390987 | Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2 |
| Q40042233 | Epidemiology of Peripheral Neuropathy: An Indian Perspective |
| Q28397017 | Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh |
| Q36094397 | Folic acid supplementation lowers blood arsenic |
| Q42580083 | Further comments on chronic arsenic poisoning |
| Q28395582 | Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism |
| Q36104172 | Molecular and ionic mimicry and the transport of toxic metals. |
| Q47648655 | Murshidabad--one of the nine groundwater arsenic-affected districts of West Bengal, India. Part II: dermatological, neurological, and obstetric findings. |
| Q23915955 | Neurologic evaluation of a population exposed to arsenic in Alaskan well water |
| Q39645196 | Neurophysiological approaches to the detection of early neurotoxicity in humans |
| Q44722738 | Neurosensory effects of chronic human exposure to arsenic associated with body burden and environmental measures |
| Q67845309 | Occupational and environmental exposure to arsenic — increased urinary arsenic level in children |
| Q48637668 | Occupational and environmental neurology: a pioneer. In memorium: Robert G. Feldman, MD, 1933-2003. |
| Q28386197 | Occupational peripheral neuropathies |
| Q70153726 | Peripheral neuropathy and vibration syndrome. A clinical and neurophysiological study of 103 patients |
| Q28344294 | Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiological study |
| Q33954094 | Peripheral neurotoxic disorders |
| Q23918589 | Persistent neuropathy and hyperkeratosis from distant arsenic exposure |
| Q28391045 | Possibilities of detecting health effects by studies of populations exposed to chemicals from waste disposal sites |
| Q43106277 | Prenatal and early life arsenic exposure induced oxidative damage and altered activities and mRNA expressions of neurotransmitter metabolic enzymes in offspring rat brain |
| Q34636639 | Role of the neurologist in hazard identification and risk assessment |
| Q39257145 | Subacute arsenic neuropathy: clinical and electrophysiological observations |
| Q34137121 | Systemic uptake of inhaled arsenic in rabbits |
| Q52006368 | The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. |